Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome and Proceedings of AGM29-12-2020
29-12-2020
Concord Drugs Ltd - 538965 - Reg. 34 (1) Annual Report
Annual Report for the Financial Year 2019-2007-12-2020
Concord Drugs Ltd - 538965 - Fixes Book Closure for AGM (Cut-off date for e-voting)
Concord Drugs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 23, 2020 to December 29, 2020 (both days inclusive) for the purpose of 25th Annual General Meeting (AGM) of the Company to be held on December 29, 2020.05-12-2020
Concord Drugs Ltd - 538965 - Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2020
Unaudited Financial Results for the Quarter and Half year ended 30.09.202013-11-2020
Concord Drugs Ltd - 538965 - Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2020
Unaudited Financial Results for the Quarter and Half year ended 30.09.202013-11-2020
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended And Half Year Ended 30.09.2020
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve Unaudited Financial Results for the Quarter ended and Half year ended 30.09.202004-11-2020
Concord Drugs Ltd - 538965 - Compliance Certificate Under Regulation 7(3) Of SEBI(Listing Obligation And Disclosure Requirements) Regulations,2015 For The Half Year Ended 30.09.2020.
compliance certificate under regulation 7(3) of SEBI(Listing Obligation And Disclosure Requirements) Regulations,2015 for the half year ended 30.09.2020.28-10-2020
Concord Drugs Ltd - 538965 - Compliance Certificate U/R 40 (9) Of SEBI(Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30.09.2020.
Compliance Certificate u/r 40 (9) of SEBI(Listing Obligation and Disclosure Requirements) Regulations, 2015 for the half year ended 30.09.2020.27-10-2020
Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the Quarter ended 30.09.2020.27-10-2020